JENNINGS NARANJO: Open Payments
NPI 1881164960 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 10 payments from 7 companies in 2025. Trend: 2023 $414 · 2024 $458 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Radius Health, Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $16 |
| Insulet Corporation | 1 | $15 |
Products named: Dexcom G6 Transmitter, JARDIANCE, CAPLYTA, GVOKE HYPOPEN, Tymlos, AMS 700, Omnipod.
Industry payments across TX — which companies pay providers there.
